Spectral Med Stock Market Value
| EDTXF Stock | USD 0.60 0.03 4.76% |
| Symbol | Spectral |
Spectral Med 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Spectral Med's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Spectral Med.
| 04/22/2025 |
| 07/21/2025 |
If you would invest 0.00 in Spectral Med on April 22, 2025 and sell it all today you would earn a total of 0.00 from holding Spectral Med or generate 0.0% return on investment in Spectral Med over 90 days. Spectral Med is related to or competes with BioMark Diagnostics, DarioHealth Corp, Spectral Med, Copper Fox, and DroneShield. Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for ... More
Spectral Med Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Spectral Med's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Spectral Med upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.11 | |||
| Information Ratio | 0.0307 | |||
| Maximum Drawdown | 16.32 | |||
| Value At Risk | (3.45) | |||
| Potential Upside | 4.84 |
Spectral Med Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spectral Med's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Spectral Med's standard deviation. In reality, there are many statistical measures that can use Spectral Med historical prices to predict the future Spectral Med's volatility.| Risk Adjusted Performance | 0.0847 | |||
| Jensen Alpha | 0.1841 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.0262 | |||
| Treynor Ratio | 0.9871 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Spectral Med's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Spectral Med Backtested Returns
At this point, Spectral Med is extremely dangerous. Spectral Med owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0338, which indicates the firm had a 0.0338 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Spectral Med, which you can use to evaluate the volatility of the company. Please validate Spectral Med's Semi Deviation of 1.75, coefficient of variation of 1194.67, and Risk Adjusted Performance of 0.0847 to confirm if the risk estimate we provide is consistent with the expected return of 0.0865%. Spectral Med has a performance score of 2 on a scale of 0 to 100. The entity has a beta of 0.22, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Spectral Med's returns are expected to increase less than the market. However, during the bear market, the loss of holding Spectral Med is expected to be smaller as well. Spectral Med right now has a risk of 2.56%. Please validate Spectral Med jensen alpha and the relationship between the value at risk and day median price , to decide if Spectral Med will be following its existing price patterns.
Auto-correlation | -0.37 |
Poor reverse predictability
Spectral Med has poor reverse predictability. Overlapping area represents the amount of predictability between Spectral Med time series from 22nd of April 2025 to 6th of June 2025 and 6th of June 2025 to 21st of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Spectral Med price movement. The serial correlation of -0.37 indicates that just about 37.0% of current Spectral Med price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.37 | |
| Spearman Rank Test | 0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Spectral Med lagged returns against current returns
Autocorrelation, which is Spectral Med pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Spectral Med's pink sheet expected returns. We can calculate the autocorrelation of Spectral Med returns to help us make a trade decision. For example, suppose you find that Spectral Med has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Spectral Med regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Spectral Med pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Spectral Med pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Spectral Med pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Spectral Med Lagged Returns
When evaluating Spectral Med's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Spectral Med pink sheet have on its future price. Spectral Med autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Spectral Med autocorrelation shows the relationship between Spectral Med pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Spectral Med.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Spectral Pink Sheet
Spectral Med financial ratios help investors to determine whether Spectral Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.